Retail Clinics

WEST CONSHOHOCKEN, Pa. — Hope Paige Medical has introduced a new line of short message, service-enabled medical jewelry that is designed to quickly provide patients' medical information via text message.

DOYLESTOWN, Pa. — ProPhase Labs on Tuesday launched the Cold-Eeze oral spray, which is formulated with zinc gluconate to help reduce the severity and duration of the common cold.

BOSTON — Employee wellness experts from Babcock & Wilcox, Caesars Entertainment and others spoke to the synergies that such a company as Walgreens' Take Care Health Systems can create across their health management strategies during a panel discussion here last week at the National Conference on Health, Productivity and Human Capital hosted by the National Business Group on Health.

Representing businesses that collectively employ more than 120,000 workers, the panelists discussed a number of emerging themes in employer-sponsored health care, including:

WASHINGTON — President Barack Obama issued an executive order Monday to address the growing problem of drug shortages.

NEW YORK — New York City mayor Michael Bloomberg and health commissioner Thomas Farley received their seasonal flu vaccine on Saturday at a Duane Reade pharmacy in the Bronx, demonstrating the importance of taking steps to prevent the spread of the virus.

“Every year, New Yorkers lose their lives to the flu, and a flu shot is the single most important protection against getting sick and spreading the flu to others,” Bloomberg said. “I urge everyone to go to their doctor, local health clinic or pharmacy and get a flu shot as soon as they can.”

DEERFIELD, Ill. — Select Walgreens across the country will offer free blood-glucose testing during National Diabetes Month this November, Walgreens announced Monday.

WASHINGTON — Sen. Charles Schumer, D-N.Y., on Monday became the 11th senator to sign on as a co-sponsor for the Medication Therapy Management Empowerment Act of 2011. The legislation was first introduced in February by Sen. Kay Hagan, D-N.C.

PHILADELPHIA — The Food and Drug Administration has approved a generic version of a short-term adjunct treatment for obesity.

Lannett said that the FDA approved its abbreviated new drug application for phentermine resin extended-release capsules in the 15-mg and 30-mg strengths. The drug, which is equivalent to UCB's Ionamin, will be sold in bariatric clinics.